Neuromodulation of the median nerve in carpal tunnel syndrome, a single-blind, randomized controlled study.

Gevher Rabia Genc Perdecioglu Mehlika Panpallı Ateş Damla Yürük Omer Taylan Akkaya

Published in: The Korean journal of pain (2023)

: NiPRF effectively improves symptoms and functionality in patients with CTS for up to 3 months. Thus, NiPRF can be considered an easy, safe, and useful alternative treatment modality for CTS.

Keyphrases

double blind
open label
phase iii
placebo controlled
phase ii
clinical trial
physical activity
replacement therapy
peripheral nerve